Precision therapy of rivaroxaban in a patient with low-body-weight and polypharmacy patient:a case report
Anticoagulation therapy needs to constantly weigh the risk of thrombosis and bleedings.For special popula-tions undergoing anticoagulation therapy,individual characteristics of patients and influencing factors of anticoagulant therapy should be more clearly defined,and individualized treatment strategies should be developed.This article offered a case of riva-roxaban anticoagulation therapy practice in a patient with low body weight and polypharmacy,with the participation of clini-cal pharmacists.It covers the selection of anticoagulant drugs,dosage adjustment,and methods and processes of pharmaceuti-cal care.Such patients always have a high risk of both anticoagulation bleeding and recurrent thrombosis.Clinical pharmacists designed an evidence-based individualized dosing regimen according to the specific conditions of the patient and ensured the effectiveness and safety of anticoagulation therapy through the monitoring of rivaroxaban blood concentration,which helped to achieve the best outcome of anticoagulant therapy for the patient.
low body weightpolypharmacyrivaroxabantherapeutic drug monitoring
NETL
NSTL
万方数据
